Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial

Abstract Background Although clozapine is an effective option for treatment-resistant schizophrenia (TRS), there are still 1/3 to 1/2 of TRS patients who do not respond to clozapine. The main purpose of this randomized, double-blind, placebo-controlled trial was to explore the amisulpride augmentati...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Ming-Huan Zhu, Zhen-Jing Liu, Qiong-Yue Hu, Jia-Yu Yang, Ying Jin, Na Zhu, Ying Huang, Dian-Hong Shi, Min-Jia Liu, Hong-Yang Tan, Lei Zhao, Qin-Yu Lv, Zheng-Hui Yi, Feng-Chun Wu, Ze-Zhi Li
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	KeAi Communications Co., Ltd. 2022-10-01
श्रृंखला:	Military Medical Research
विषय:	Schizophrenia Clozapine-resistant treatment refractory schizophrenia Clozapine Amisulpride Augmentation
ऑनलाइन पहुंच:	https://doi.org/10.1186/s40779-022-00420-0
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!